Citi Analysis Predicts Prime Medicine Shares to Soar by Over 45%
Thursday, 16 May 2024, 14:02
Prime Medicine Stock Projections
Citi's Samantha Semenkow predicts that Prime Medicine's stock is due to surge by over 45% following a period of underperformance.
Market Analysis by Citi
The market analysis conducted by Citi highlights the potential for Prime Medicine shares to regain favor among investors.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.